Cited by 1,167Alzheimer's disease research and treatmentsCellular transport and secretionDementia and Cognitive Impairment Research

The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease

Open access
Rogaeva, Ekaterina, Meng, Yan, Lee, Joseph H, Gu, Yongjun, Kawarai, Toshitaka, Zou, Fanggeng, Katayama, Taiichi, Baldwin, Clinton T +33 more·2007·Nature Genetics

Abstract

The recycling of the amyloid precursor protein (APP) from the cell surface via the endocytic pathways plays a key role in the generation of amyloid beta peptide (Abeta) in Alzheimer disease. We report here that inherited variants in the SORL1 neuronal sorting receptor are associated with late-onset Alzheimer disease. These variants, which occur in at least two different clusters of intronic sequences within the SORL1 gene (also known as LR11 or SORLA) may regulate tissue-specific expression of SORL1. We also show that SORL1 directs trafficking of APP into recycling pathways and that when SORL1 is underexpressed, APP is sorted into Abeta-generating compartments. These data suggest that inherited or acquired changes in SORL1 expression or function are mechanistically involved in causing Alzheimer disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ng1943

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • SORL1 was identified through GWAS as a risk factor for sporadic AD.

    “SORL1 was identified through GWAS as a risk factor for sporadic AD (495, 503).”

    From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [503]

    The Results section reports an association between SORL1 variants and late-onset AD, and the Discussion describes a modest effect on AD risk. But the Results describe screening SNPs in seven selected genes, initially in familial AD datasets—not identifying SORL1 through a genome-wide association study (GWAS). No page numbers are available in our copy. (LLM, conf=0.91)

    Experimental — accuracy not yet measured
  • LR11/SorLA variants are genetically associated with AD.

    “Genetic association of LR11/SorLA variants with AD further corroborates its mechanistic link to AD pathogenesis (Rogaeva et al., 2007).”

    From The role of apolipoprotein E in Alzheimer's disease (2009) · cites this paper as Rogaeva et al., 2007

  • The genetic association of LR11/SorLA variants with AD corroborates its mechanistic link to AD pathogenesis.

    “Genetic association of LR11/SorLA variants with AD further corroborates its mechanistic link to AD pathogenesis (Rogaeva et al., 2007).”

    From The role of apolipoprotein E in Alzheimer's disease (2009) · cites this paper as Rogaeva et al., 2007

  • Overexpression of SORLA in neuronal cells blocks amyloidogenic processing and reduces Aβ production, whereas loss of SORLA increases extracellular Aβ levels and plaque deposition in several AD mouse models.

    “Overexpression of SORLA in neuronal cells can block amyloidogenic processing and reduce Aβ production [485], whereas loss of SORLA increased extracellular Aβ levels and plaque deposition in several AD mouse models [486, 487].”
  • SORL1 is a sorting receptor located in neurons, astrocytes, and microglia and is known to direct APP toward non-amyloidogenic processing in the trans-Golgi network.

    “SORL1, a sorting receptor located in neurons [152], astrocytes, and microglia [153] is known to direct APP toward non-amyloidogenic processing in the trans-Golgi network [148, 154].”

    From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [154]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [20]Rogaeva E, et al. Re-analysis of the association of Alpha-2-macroglobulin and Alzheimer’s Disease. Nature Genet. 1999;22:19–22. [Google Scholar]

Cited by

Sorted by citations

Authors
Rogaeva, E., Meng, Y., Lee, J. H., Gu, Y., Kawarai, T., Zou, F., Katayama, T., Baldwin, C. T., Cheng, R., Hasegawa, H., Chen, F., Shibata, N., Lunetta, K. L., Pardossi-Piquard, R., Bohm, C., Wakutani, Y., Cupples, L. A., Cuenco, K. T., Green, R. C., Pinessi, L., Rainero, I., Sorbi, S., Bruni, A., Duara, R., Friedland, R. P., Inzelberg, R., Hampe, W., Bujo, H., Song, Y.-Q., Andersen, O. M., Willnow, T. E., Graff-Radford, N., Petersen, R. C., Dickson, D., Der, S. D., Fraser, P. E., Schmitt-Ulms, G., Younkin, S., Mayeux, R., Farrer, L. A., & St George-Hyslop, P.
Affiliations
  • University of Toronto (CA)
  • Boston University (US)
  • Columbia University (US)
  • Mayo Clinic (US)
  • University of Turin (IT)
  • University of Florence (IT)
  • University of Miami (US)
  • Case Western Reserve University (US)
  • Technion – Israel Institute of Technology (IL)
  • University Medical Center Hamburg-Eppendorf (DE)
  • Chiba University (JP)
  • University of Hong Kong (HK)
  • Max Delbrück Center (DE)
Corresponding author
  • Mayeux, Richard
  • Farrer, Lindsay A
Venue
Nature Genetics
Published
2007-01-14
Volume
39
Issue
2
Pages
168-177
ISSN
  • 1061-4036 (ISSN-L)
  • 1546-1718
OpenAlex
W2058880763
Cited by
1,167
References
50
Citations by year
2026: 24 · 2025: 41 · 2024: 46 · 2023: 39 · 2022: 36 · 2021: 54 · 2020: 50 · 2019: 46 · 2018: 53 · 2017: 58 · 2016: 71 · 2015: 50 · 2014: 71 · 2013: 55 · 2012: 85
FWCI
71.23
Type
journal article
Language
en
Open access
Locations
  • Nature Genetics (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
  • Florence Research (University of Florence) (submittedVersion)
  • The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
  • Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
Funders
  • National Institutes of Health (5r37ag015473-15)
  • National Institute on Aging (R01-HG/AG-02213, P50‐AG16574, R37AG15473, U01AG06786, P01AG007232, R37-AG015473, U01AG006786, P01AG07232, P30AG013846, R01AG009029, R01AG017173, R01 AG09029, P30-AG13846), P50AG016574)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
SORL1, Alzheimer's disease, late-onset Alzheimer's disease, amyloid precursor protein, amyloid-beta, endocytic pathway, genetic association, intronic variants, tissue-specific gene expression, APP trafficking
MeSH terms
Alzheimer Disease, Cell Line, Haplotypes, Humans, Introns, Models, Genetic, Organ Specificity, Receptors, Cell Surface, Endosomes, Genetic Variation, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Age of Onset, Polymorphism, Single Nucleotide, LDL-Receptor Related Proteins, Membrane Transport Proteins, Vesicular Transport Proteins, Protease Nexins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review